healthcarereports-blog

[healthcarereports-blog]

Pharmaceuticals and Food Anti-counterfeiting Market is Set to Reach More Than $160 Billion By 2020

Proliferation of cheap but poor quality counterfeit products in the pharmaceutical and food sector and the resultant losses, are a growing concern, globally. Key anti-counterfeiting technologies include overt or visible feature enabling, covert feature enabling, forensic, and track/trace technologies. Counterfeiting not only leads to huge losses but also negatively affects brand image of industry operators. According to a recent study by Hexa Research, the global Pharmaceuticals and Food Anti-counterfeiting Market is set to reach more than $160 billion by 2020. US Food and Drug Administration (FDA), is implementing stringent anti-counterfeiting regulations and supporting development of anti-counterfeit devices. 

Technological segmentation of the market includes authentication and tracking technologies. Tracking technologies can be split into RFID and barcodes. Barcodes offer advantages like traceability, accuracy and affordability. It was the leading technology in 2013. RFID will experience exponential growth with a CAGR of about 20% from the period 2013 to 2020. Authentication is split into inks and dyes, hologram, taggants, etc. Hologram accounted for the largest market share in 2013 and will grow at a rate of more than 15.9% from 2013 to 2020. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/pharmaceuticals-and-food-anti-counterfeiting-technologies-industry/ 

Between pharmaceutical and food applications, pharmaceutical applications accounted for higher share of anti-counterfeiting products. Pharmaceutical sector places high value on quality and invests in superior technologies that prohibit patients from consuming low quality counterfeit products. Governmental regulations also play an important role in higher demand from pharmaceutical industry. However, food application is likely to witness fastest growth in the coming years, primarily due to rising awareness levels amongst market participants. 

Backed by governmental interventions and advanced healthcare infrastructure, North America, with a market valuation of about $46 billion, was the largest regional consumer of pharmaceutical and food anti-counterfeiting products in 2012. Europe was second to North America with a market share of more than 16.8%. Hexa Research opines that the fastest growth of pharmaceuticals and food anti-counterfeiting market in future years is likely to come from emerging economies such as Asia Pacific countries and Latin American countries, among others. Large scale counterfeiting practices, rising income levels and healthcare infrastructure developments in emerging markets of India, China and Brazil will drive this growth. Key players of the global pharmaceuticals and food anti-counterfeiting industry are Data System International, Sun Chemical, Datamax, Intermec Technologies, Alien Technology, Inksure Technologies, Unibar Inc., etc.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Autoimmune Disease Diagnostics Market To Grow At A Lucrative Rate By 2020 | Hexa Research

Factors that propel the global Autoimmune Disease Diagnostics Market are rising cases of autoimmune diseases and surging healthcare expenditure. Encouraging governmental policies regarding autoimmune diagnostics & research has a positive impact on market demand. Autoimmune diseases are a key cause of women deaths worldwide. Furthermore, active awareness initiatives regarding diagnosis of diseases may contribute significantly to the global industry during the forecast period (2012 to 2020). A large number of laboratories have begun installing equipment that can carry out several tests simultaneously and deliver quick results. Automation in laboratory procedures ensures greater efficiency. 

The worldwide autoimmune disease diagnostics market is categorized on the basis of products and regions. On the basis of products, there are two key segments, namely, localized disease diagnostics and systemic autoimmune disease diagnostics. Owing to greater patient awareness and huge procedure volumes, the localized disease diagnostics segment held the highest share in 2013. A number of unmet medical needs in type 1 diabetics is a key factor that drives this segment. The systemic autoimmune disease diagnostics segment mainly involves the diagnosis of diseases, such as rheumatoid arthritis, lupus erythematosus (SLE), and Ankylosing spondylitis. The rheumatoid arthritis segment holds the highest share in the industry because it is the most frequently occurring inflammatory ailment worldwide. It is led by product innovation. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/autoimmune-disease-diagnostics-industry 

On the basis of geographies, the global autoimmune disease diagnostics market is divided into Europe, Asia Pacific, North America, and Rest of the World. In revenue terms, North America was the largest market in 2013. This region is propelled by a well developed healthcare infrastructure and positive government initiatives, such as the Affordable Care Act and Patient Protection Act. 

In terms of yearly expenditure on autoimmune disease diagnostics, North America ranks number one in the overall industry. Moreover, surging per capita spending on healthcare is projected to significantly drive regional growth till 2020. Europe, the second largest market after North America, is propelled by technological advancements and high cases of autoimmune diseases. These technological developments are mainly observed in portable diagnostics equipment and biomarkers. Europe may derive much of its demand for autoimmune disease diagnostics from Eastern Europe. 

Being a highly consolidated one, the global market for autoimmune disease diagnostics market witnesses frequent mergers & acquisitions. It is a moderately competitive industry that is led by innovations and price wars. Key competitors in the global industry are Bio Rad, Crescendo Bioscience, Roche Diagnostics, Quest Diagnostics, and Abbott Diagnostics. 

In October 2016, IQuity, a diagnostics technology company launched the IQIsolate® technology. This technology helps identify autoimmune anomalies during its early stages. It analyzes the RNA structures in blood samples. Interestingly, IQIsolate® has exhibited ninety percent accuracy in three key medical specialties, namely, rheumatology, gastroenterology, and neurology. The company asserts that its technology can significantly reduce the diagnostics processes of complex autoimmune diseases. It can also differentiate between diseases that show similar symptoms. A striking feature of IQuity’s blood based diagnostic technology is that it helps providers & physicians confirm other types of autoimmune anomalies within a week. It is expected to gradually commercialize newer test panels that focus on rheumatology and gastroenterology. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Artificial Organ And Bionics Market To Grow At A Lucrative Rate By 2020 | Hexa Research

Continuous technological innovations coupled with high investments in healthcare are two key factors that fuel the global Artificial Organ and Bionics Market. Artificial organs refer to devices that are developed to replace natural organs in the human body. The need for organ transplant arises when a certain natural organ has either stopped working or doesn’t function properly. Artificial organs and artificial body parts are made from substances known as biomaterials. 

Man made hazards and high frequency of accidents may propel the global artificial organ and bionics market during the forecast period (2014 to 2020). Artificial liver, artificial limbs, artificial pancreas, artificial heart, and artificial kidneys are examples of artificial organs that function exactly like natural organs when implanted in the human body. The application of electronics & mechanics in the field of medicine has led to newer innovations in developing artificial organs.

Browse Details of Report @ https://www.hexaresearch.com/research-report/artificial-organs-and-bionics-industry

The worldwide artificial organ and bionics market is categorized on the basis of products, technologies, and regions. Based on products, the segments are artificial pancreas, artificial liver, artificial lungs, artificial heart, and artificial kidney. Medical bionics products are further subdivided into cardiac bionics, brain bionics, vision bionics, heart bionics, limb bionics, and exoskeleton bionics. Due to high prevalence of heart disorders worldwide, the segment for heart bionics holds the largest share in the overall market. The artificial lungs & kidney segments held considerable industry shares in 2013. These segments may grow substantially during the forecast period because of problems, such as alcohol abuse and consumption of drugs & cigarettes. 

On the basis of technologies, the industry is bifurcated into mechanical bionics and electronic bionics. Rapid technological advancements have led to the development of medical bionics that meets the challenges of organ failure. Mechanical bionics is mostly employed in the development of orthopedic body parts. 

As per regions, the global artificial organ and bionics market is categorized into Europe, Asia Pacific, North America, and Rest of the World. North America led the industry in 2013. Factors that fuel this region are high investments in research & development and technological advancements. Growing geriatric population, rising cases of organ failure, and high incidence of accidents may contribute to regional growth over the forecast period. However, the Asia Pacific market is poised to grow rapidly over the next couple of years. This industry is driven by steady government support, medical tourism, and surging disposable incomes. Government support has led to improvements in healthcare infrastructures. 

Companies in the worldwide artificial organ and bionics market are Second Sight Medical Product Inc.; Medtronic Co. Ltd.; World Heart Corporation; Thoratec Corporation; and Lifenet Health. Besides being monopolistic, the global market is a highly competitive one too. 

Researchers have begun examining using 3D printing in the development of artificial organs. Organovo, a U.S. based biotech startup, focuses on 3D printing of human tissues. These are then sculpted in layers to form organs. Nano Dimension, an Israeli 3D printing company in collaboration with Accellta has successfully mixed human stem cells in printing inks. Accellta is an Israel based stem cell technology company. The striking feature of the inkjet methods of Nano Dimension is the speed at which it prints the human tissues. While most 3D printing techniques take hours to perform this task, Nano Dimension’s technology does it in a matter of seconds. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Medical Nonwoven Disposables Market is Projected to Expand at a CAGR Surpassing 7.9% Till 2020

The global Medical Nonwoven Disposables Market is projected to expand at a CAGR surpassing 7.9% during the forecast period (2014 to 2020). The industry stood at USD 5980 million in 2013. Booming global population and rising cases of incontinence & related disorders are key market drivers. Other factors that fuel demand are surging income levels, sophisticated medical infrastructure, and high incidence of hospital acquired infections. 

Medical nonwoven disposables are made of special nonwoven materials that prevent cross contaminations. They effectively sieve out bacteria that spread infections. Medical nonwoven disposables are preferred over conventional textiles since the former exhibit greater protection against infections. One of its key demand drivers is the widespread acceptance of the same among medical practitioners. 

The global medical nonwoven disposables market is categorized on the basis of products and regions. The product portfolio comprises disposable nonwoven hygiene products and nonwoven medical supplies. In 2013, the industry was dominated by the nonwoven medical supplies segment. It accounts for more than 50% of total revenues. The market for hygiene products is anticipated to expand robustly over the forecast period. High adoption rate and rising cases of urinary & fecal incontinence propel demand for hygiene products. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/medical-nonwoven-disposables

The disposable incontinence pads & ostomy liners segment led the disposable nonwoven sanitation products industry in 2013. These products are essentially used in light or medium incontinence cases. It is expected that the introduction of eco-friendly & chlorine free incontinence pads will significantly contribute to market demand. 

Geographically, the worldwide medical nonwoven disposables market is categorized into four key segments: Europe, North America, Asia Pacific, and Rest of the World. Owing to high patient awareness, intense R&D activities, and the presence of updated technologies, North America dominated the global market in 2013. This region receives immense government support. 

According to recent surveys, disposable adult incontinence products are needed by nearly 29 million individuals in North America. Such a trend could further fuel regional demand during the forecast period. China and India are the two main Asia Pacific economies that are poised to witness remarkable growth in the forthcoming years. Regional market drivers are widespread awareness about hospital acquired infections and surging healthcare expenditure. 

Prominent industry players are Kimberly Clark Corporation, Svenska Cellulosa Aktiebolaget (SCA), Unicharm Corporation, Covidien, and Freudenberg Nonwovens among many others. Characterized by stiff competition, the global industry thrives on new product development and innovations. Biodegradable & gender specific diapers are expected to positively impact the market in the long run. 

Currently, the industry is witnessing high demand for nonwovens that are meant for moderate & heavy incontinence. These products include pull up pants and protective adult underwear. Manufacturers need to ensure that these products rank high on softness, stretchability, and strength. FIBRELLA Lite nonwoven is the award winning product manufactured by Suominen, a Finland based manufacturer of nonwovens. It is a lightweight spunlace nonwoven that is widely available and is employed in adult incontinence & baby care applications. This material employs excellent bonding, finishing, and forming technologies. Introduction of this product has enabled Suominen to expand its customer base considerably. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Peptide Therapeutics Market to Witness Robust Growth Till 2020

Rising cases of cancer and high incidence of a number of metabolic diseases propel the global Peptide Therapeutics Market. Other industry drivers are prevalence of lifestyle diseases, introduction of hybrid methods of peptides synthesis, growing global population, and improved healthcare infrastructure. A molecule containing two or more amino acids is known as a peptide. Therapeutic peptides are short amino acid monomer chains. 

Peptides are commonly known as amide bonds. These are used to treat blood-based disorders, certain types of cancers, chronic ailments, CNS (central nervous system) disorders, and cardiovascular & respiratory anomalies. Growing importance of peptide therapeutics in the pharmaceutical market may significantly contribute to overall demand during the forecast period (2012 to 2020). However, changing customer needs and lack of regulatory standards hinder industry progress. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/peptide-therapeutics-industry 

The worldwide peptide therapeutics market is categorized on the basis of technologies, applications, routes of administration, products, and regions. Based on technologies, the segments are HPPS (hybrid phase peptide synthesis), LPPS (liquid phase peptide synthesis), and SPPS (solid phase peptide synthesis). Owing to cost effectiveness and user-friendliness, SPPS was the largest contributor to the overall industry in 2013.On the basis of applications, the market is divided into respiratory, cancer, anti-infection, pain, metabolic, cardiovascular, dermatology, renal, gastro intestinal, and others. In 2013, peptide therapeutics were used extensively in cancer treatment. High incidence of cancer cases worldwide is expected to fuel this segment till 2020. 

According to routes of administration, the industry is segmented into mucosal, pulmonary, parenteral, oral, and others. “Others” includes nasal and intradermal. Parenteral held the highest industry share in 2013. Based on products, the bifurcations are generic and innovative. Innovative peptides dominated the overall industry in 2013. 

As per regions, the global peptide therapeutics market is categorized into Europe, Asia Pacific, North America, and Rest of the World. North America leads the global industry because of high per capita expenditure on healthcare, rising income levels, and improvements in healthcare infrastructure. The region receives substantial support from the government and also from a number of NGOs. 

Asia Pacific may witness robust growth over the forecast period because of economic progress, favorable government initiatives, and growing population. Japan, China, and India are the three key regional drivers of the Asia Pacific market. Prominent companies operating in the global peptide therapeutics market are Eli Lilly and Company; Takeda Pharmaceutical Company Ltd.; Amylin Pharmaceuticals LLC; Bachem Holding AG; and Teva Pharmaceuticals. 

Rhythm, a U.S. based biopharmaceutical company dealing in peptide therapeutics presented the phase 2 clinical trial assessment of setmelanotide in November 2016. Setmelanotide, a peptide drug, is the company’s melanocortin-4 receptor agonist that is generally used to treat LepR (leptin receptor) deficiency obesity. This is a rare genetic anomaly that leads to unrelenting hyperphagia and severe obesity. According to the company, this disorder affects nearly two thousand people in the U.S. on an annual basis. 

Caused by deficiencies & defects in the MC4 pathway, LepR deficiency obesity affects people in their early childhood. The MC4 pathway in humans regulates appetite, energy expenditure, and homeostasis. Setmelanotide’s efficacy was tested by researchers when it was administered everyday by subcutaneous injection. Over a period of 22 weeks, a LepR patient lost weight by almost 20%. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Medical Specialty Bags Market To Show Higher CAGR Globally Till 2020 | Hexa Research

Growing geriatric population and patient awareness are two vital factors that propel the global Medical Specialty Bags Market. Urinary incontinence & dissoluteness are commonly occurring problems among the elderly; especially those above 60 years of age. Thus, the growing need for effective solutions to tackle this age-related problem could positively impact the overall industry from 2012 to 2020 (forecast period). Surging expenditure on healthcare also supports the industry. 

Medical specialty bags are products that help curb & manage problems that stem from conditions, such as bile leakage and bowel incontinence. The performance of the global market depends significantly on new product innovation and technological advancements. The need for specialty bags arises during surgical procedures, such as laparoscopic surgeries and urinary surgical procedures. Moreover, high incidence of cancer, cardiovascular disorders, and cancer fuel industry demand. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/medical-specialty-bags-industry 

The worldwide medical specialty bags market is categorized as per products, applications, and geographies. Based on products, the categories are cadaver bags, ice bags, intravenous fluid bags, ostomy collection bags, CAPD (continuous ambulatory peritoneal dialysis) bags, enema bags, resuscitation bags, blood bags, enteral feeding bags, sterile packaging bags, bile collection bags, urinary collection bags, and anesthesia breathing bags. Ostomy collection bags are ideal for patients suffering from urinary dissoluteness. This product segment is expected to witness high demand over the forecast period.

The global market is characterized by continuous improvements in medical standards & facilities. Such a trend could have a positive impact on product demand in the forthcoming years. Furthermore, heightened awareness among the masses not just about health but also hygiene may fuel the medical specialty bags industry in the years to come. As per applications, the segments are SurgiCenters, hospitals & medical centers, and home healthcare. Due to widespread awareness and surging demand, SurgiCenters may augment industry growth. 

Geographically, the global market is divided into Asia Pacific, North America, Europe, and Rest of the World (RoW). Owing to high disposable incomes and rising per capita spending on healthcare, North America dominates the overall market. Other regional drivers are advanced healthcare infrastructure and implementation of several government initiatives. The active participation of NGOs has also played a vital role in supporting the North America market. The region contributed to more than 42% of overall revenues in 2013. However, current industry trends suggest that Asia Pacific may lead the global industry till 2020. Factors that drive this region are economic development, favorable government initiatives, and growing geriatric population. 

Key companies in the global medical specialty bags market are Pall Corporation, Westfield Medical Ltd., B Braun Medical, Coloplast A/S, and Terumo Corporation. PVC (polyvinyl chloride) is the most commonly used material in the bag & tubing industry. However, there are a number of OEMs (original equipment manufacturers) that seek alternative materials to replace PVC. Ethylene vinyl acetate (EVA) polymers generally do not need plasticizers. Ateva® G EVA polymers manufactured by Celanese Corporation is a widely accepted product in parenteral nutrition bag applications. This product is ideal for OEMs that aim at offering nutrition bags that are 100% non PVC-based. Celanese Corporation is a Fortune 500 specialty materials company based in Texas, U.S. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Point of Care (POC) Diagnostics Market to Grow Substantially Till 2020

The global Point Of Care Diagnostics Market is driven by technological improvements and introduction of sophisticated medical solutions. A host of healthcare establishments are gradually taking to point of care tests and diagnostics solutions for greater efficiency. Growing popularity of EMR (electronic medical record) and PACS (picture archiving and communication systems) has a positive impact on market demand. 

Other industry drivers are governmental support, surging healthcare investments, growing geriatric population, and widespread adoption of home based POC devices. When medical diagnostics tests are carried out at the place of patient care, it is known as bedside testing or POCT (point-of-care-testing). New product development is a vital factor that may contribute significantly to market growth during the forecast period (2012 to 2020). 

Browse Details of Report @ https://www.hexaresearch.com/research-report/point-of-care-diagnostics-industry 

Products, end users, and regions are the parameters based on which the global point of care (POC) diagnostics industry is categorized. As per products, the segments are blood gas/electrolytes, fertility, cardiac markers, OTC & rapid diagnostic tests, infectious diseases, coagulation, drug abuse testing, hospital glucose testing, decentralized clinical chemistry, hematology, and urinalysis. Products also include primary care systems, such as HbA1c tests and lipid profiling. Hospital glucose testing holds the highest market share. Factors that propel this segment are high incidence of diabetes and the growing necessity for glucose analysis on a regular basis. 

The OTC & rapid diagnostic tests market may expand robustly over the forecast period because of the “self diagnosis” trend. People nowadays are highly aware of the importance of early disease diagnosis for on-time & instant disease treatment. Based on end users, the global industry is divided into laboratories, hospitals, clinics, assisted living healthcare facilities, homes, and others. Hospitals & clinics generate highest revenues in the overall market. Diagnostic tests are mostly conducted in clinics and in hospitals. As a result, most of these healthcare centers have begun expanding their POC diagnostic facilities. 

Geographically, the worldwide Point Of Care Diagnostics Market is categorized into Asia Pacific, Europe, North America, and Rest of the World (RoW). North America is the largest regional industry. High degree of patient awareness, encouraging government initiatives, and substantial investments in medical infrastructure are prominent regional drivers. It is however, expected that Asia Pacific will register the highest growth rate over the forecast period. This attributes to improvements in healthcare infrastructure in emerging countries, such as India and China. 

Companies operating in the global Point Of Care Diagnostics Market continuously strive towards capturing higher market shares. They invest robustly in R&D and product innovations. Prominent market competitors are Trinity Biotech PLC, Danaher Corporation, Siemens Healthcare, Roche Diagnostics, and Becton Dickinson and Company. 

In September 2016, Novartis launched the NijiTM System and Total IgE Test, a POC diagnostic tool. By using just a droplet or two of finer stick blood, this device delivers Immunoglobulin E (IgE) levels in a matter of twelve minutes. This test caters to immediate in-office diagnosis of allergies associated with IgE levels. The availability of such tests in the offices of healthcare providers leads to reduced time for consultation, diagnosis, prognosis, and disease treatment. This in turn leads to better patient outcomes. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Bioinformatics Market to Reach Nearly USD 14 Billion by 2020

The global Bioinformatics Market is projected to expand at a CAGR over 21% during the forecast period (2014 to 2020). In revenue terms, the industry could reach nearly USD 14 billion by 2020. It is propelled by growing demand for advanced drugs and prevalence of chronic diseases. Application of information technology for the effective management of biological information is known as bioinformatics.

Affordable costs of DNA sequencing and strong support from private sector organizations & governments are factors that positively impact the global industry. Furthermore, steady developments in IT support for bioinformatics systems may fuel market demand in the forthcoming years. A number of research institutes focus greatly on discovering & developing novel drugs in the area of life sciences. Widespread adoption of bioinformatics in clinical diagnostics is a vital industry driver.

The global bioinformatics market is segmented on the basis of sectors, products & services, applications, and regions. Based on sectors, the industry is divided into environment biotechnology, animal biotechnology, forensic biotechnology, agriculture biotechnology, academics, forensic biotechnology, and medical biotechnology. The forensic biotechnology segment is a rapidly growing one because of high demand for DNA evidence in legal systems.

Browse Details of Report @ https://www.hexaresearch.com/research-report/bioinformatics-industry The sub-segments of medical biotechnology are reproductive biotechnology, clinical diagnostics, drug development, gene therapy, and molecular medicines. Owing to high sunk costs, medical biotechnology holds the highest share in the overall market in terms of revenue. According to products & services, the worldwide industry is categorized into bioinformatics services, bioinformatics platform, and bioinformatics knowledge management tools. Bioinformatics tools are further segmented into generalized knowledge management tools and specialized knowledge management tools. Bioinformatics platforms include sequence alignment platforms, sequence analysis platforms, functional & structural analysis platforms, and sequence manipulation platforms.

Bioinformatics services are classified into database management, sequencing service, data analysis, and others. Data analysis and database management are by far the most expensive because of these need human intervention for interpretation and technology for data organization. On the basis of applications, the global Bioinformatics Market is divided into molecular phylogenetics, proteomics, metabolomics, chemo informatics & drug design, transcriptomics, and others. Genomics is anticipated to be the largest market by 2020. And metabolomics may register the highest growth rate during the forecast period.

The regional segments of the global Bioinformatics Market are Asia Pacific, North America, Europe, and Rest of the World. North America dominated the overall industry in 2014 owing to technological developments and continuous efforts towards drug discovery & development. The region may retain its leading position throughout the forecast period. Asia Pacific may expand at a remarkable rate because of medical tourism, high investments in healthcare IT, and greater CRO activities. Brazil, China, and India could create significant growth prospects in the forthcoming years.

Prominent companies operating in the global industry are Life Technology Corporation, Biomax Informatics AG, CLC Bio, Id Business Solutions, and Nonlinear Dynamics Ltd. In order to understand & block the progression of cancer, researchers have identified certain proteins that get altered in different types of cancers. When these are targeted with drugs that block their activities, the progression of cancer can be halted to an extent. Researchers & scientists from the University of Cambridge and from Hungary utilized databases of genes that are involved in cancer.

It was observed that cancer related proteins are strongly connected to the main protein networks. Some of the key proteins in the networks have the capacity to facilitate changes that convert healthy cells into cancer cells. The cancer proteins do not interact directly with another but through their surrounding first neighbors. The concerned researchers have successfully utilized computational methods to identify the exact proteins that need to be targeted by drugs.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Ablation Technology Market To Grow At A Lucrative Rate By 2020 | Hexa Research

The global Ablation Technology Market is primarily driven by high incidence of chronic illnesses, such as cancer. Rising cancer cases fuel the need for minimally invasive procedures for diagnostics purposes. Surgical removal of body tissues is carried out by minimally invasive procedures. These procedures employ ablation technologies. Besides being economical, ablation technologies ensure quick recovery and cause lesser damage to body tissues. They also ensure lower risks of infection.

Favorable government initiatives and a rapidly growing geriatric population are factors that positively impact demand. Owing to high success rates in diagnosis of chronic illnesses and minimal risks, developing economies, such as Brazil, India, Russia, and China are gradually adopting ablation technologies. It is anticipated that popularity of minimally invasive procedures and surging per capita expenditure on healthcare may propel the ablation technology market during the forecast period (2012 to 2020).

Browse Details of Report @ https://www.hexaresearch.com/research-report/ablation-technology-industry

The worldwide industry is segmented on the basis of technologies, applications, and regions. Based on technologies, the Ablation Technology Market is divided into radiofrequency, ultrasound, electrical, and radiation. Due to widespread scope in cancer diagnosis, radiation technology led the global market in 2013. Other factors that may positively impact this segment in the forthcoming years are availability of different types of radiation devices and high incidence of cancer. The segment for electrical ablation may expand robustly over the forecast period. This attributes to rising prevalence of cardiovascular disorders, such as atrial fibrillation.

Ablation technologies are predominantly applied in orthopedics, ophthalmology, cardiovascular procedures, and in cancer. Use of ablation technologies in cancer diagnosis generated the highest revenues in 2013. Growing awareness about the popularity of ablation technology in cancer treatment is projected to fuel overall market demand. Cardiovascular applications are expected to increase considerably over the forecast period.

Geographically, the global ablation technology market is fragmented into Europe, Asia Pacific, North America, and Rest of the World. North America held highest shares in the overall industry back in 2013. Awareness about ablation technologies and large number of people suffering from chronic diseases are key regional drivers. Ongoing industry trends suggest that Asia Pacific may expand remarkably in the years to come. The region is essentially propelled by surging healthcare expenditure and application of ablation technologies in diagnostics solutions. Growing preference for ablation over surgeries and substantial government spending on ablation technology could further contribute to regional demand.

Key companies operating the worldwide market are Boston Scientific Corporation, Olympus Corporation, AngioDynamics Inc., Medtronic Inc., and AtriCulture Inc. among others. Most industry participants focus greatly on innovations that aim at enhancing accuracy & efficiency of test results. Researchers have developed a cryoablation system that can attain much cooler temperatures than most conventional cryoablation technologies.

The new system can effectively create transmural ventricular lesions from the epicardium as well as the endocardium. It may prove beneficial for catheter-based & surgical ventricular tachycardia ablations in humans. This cryoablation technology utilizes liquid nitrogen and achieves temperatures as low as minus 160 degrees Celsius. This IceSense cryoablation system helps debulk tumors in lungs, kidneys, liver, and breast. It comprises a freezing element and a rigid probe that has a sharp needle tip.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Dental Equipment Market Set To Reach USD 8.5 Billion Globally By 2020

The global Dental Equipment Market is poised to reach nearly USD 8.5 billion by 2020. The industry is driven by high incidence of dental infections & diseases. Unhealthy eating habits and rising consumption of junk foods, alcohol, chocolates, and tobacco are factors that propel demand for dental equipment. The industry is led by technological innovations that lead to simplicity & cost effectiveness. Rising cases of periodontal diseases and dental caries could propel the market for tooth implantations over the forecast period (2012 to 2020). Demand for dental radiology equipment may also increase significantly during this time because of enhanced quality and higher efficiency.

Other global industry drivers are availability of sophisticated technologies, growing geriatric population, and growing cases of tooth loss. Medical tourism too may positively influence the overall industry. The dental equipment market in most emerging economies could witness robust growth in the forthcoming years. This attributes to greater consciousness among the masses about the significance of dental health & hygiene. However, high costs of sophisticated technologies in dentistry and surging demand for refurbished dental equipment are factors that hinder industry growth.

Browse Details of Report @ https://www.hexaresearch.com/research-report/dental-equipment-industry

The global dental equipment market is segmented on the basis of products and regions. As per products, the classifications are hygiene maintenance devices, dental radiology equipment, systems & parts, laboratory machines, dental lasers, and others. “Others” includes chairs, hand piece, light cure, and scaling unit. Dental systems & parts generated the highest revenues in the overall market in 2013. Due to technological advancements, this segment may continue dominating the industry throughout the forecast period.

The dental systems & parts segment is further divided into the following: furnace & ovens, cone beam Ct systems, cast machine, instrument delivery systems, electrosurgical equipment, vacuums & compressors, CAD (computer-aided design) /CAM (computer-aided manufacturing) and other system & parts. In revenue terms, CAD/CAM held the highest market share in 2013 and may continue leading the industry in the near future.

Geographically, the global industry is categorized into Asia Pacific, Europe, North America, and Rest of the World. North America dominated the industry in terms of revenue in 2013. Regional drivers are technological developments in healthcare, substantial investments in research & development, and growing geriatric population. Asia Pacific economies, such as Brazil, Japan, China, South Korea, and India could witness significant market growth during the forecast period. Owing to gaps in demand & supply of dental treatment, these regions offer a host of opportunities for further market progress. Prominent companies operating in the overall industry are Planmeca Oy, BIOLASE Technology, Ivoclar Vivadent, Danaher Corporation, and Dentsply International. Characterized by stiff competition, the market witnesses frequent business ventures and new product developments.

In December 2016, DenMat launched the VisiLite Pro, an oral lesion screening device that is based on light based fluorescence technology. This system helps detect epithelial dysplasia in its early stages. Dentists can effectively incorporate this system into the conventional neck and head exam in order to rule out oral cancer. Fluorescence visualization offers entirely new visual information which is quite different from what doctors get while looking at reflected lights from chemiluminescent or white light sources.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Europe Aerosol Container Market Set to Reach $1.4 Billion By 2022

The Europe Aerosol Container Market is likely to surpass USD 1.4 billion (in terms of sales) by 2022. Increased use of aerosol containers in paints, household, & medical sectors should propel the market over the forecast period (2015 to 2022). Higher demand for cosmetic products in Italy, U.K., Germany, and France will also boost market revnues. 

Moreover, demand for aerosol containers from the industries of automotives and food & beverages may contribute market expansion. The market is categorized as per products, applications, and nations. Products are metals, glasses, and plastics. Metals dominated the market in 2014. They would undergo substantial growth during the forecast period, at over 3.2% CAGR. 

Raw materials are adopted due to their light weight & strong barrier features. In addition, they can be molded & printed into various designs. This is done without compromising on their structural reliability. This can also drive the Europe aerosol container market in the near future. Plastics generated more than USD 8 million in 2014. 

Browse Details of Report @  https://www.hexaresearch.com/research-report/europe-aerosol-container-market 

Applications include household, personal care, medical, paints, and others. Personal care dominated the market in 2014, producing over USD 500 million. Greater usage of aerosol containers for making body sprays, antiperspirants, hair sprays, & after shaves is expected to add market demand till 2022. 

Medical will experience the fastest expansion in the seven years ahead. It would rise at over 5% CAGR during the same period. Wider aerosol adoption across pressurized metered-dose inhalers for asthma can propel medical applications. Nations-wise, U.K. was the biggest market manufacturer in 2014. This country contributed over 25% of the total volumes the same year. 

National awareness regarding the advantages of aerosol containers is projected to drive U.K.’s production volumes from 2015 to 2022. Demand from Germany stood over USD 200 million in 2014. It should observe a significant boost over the forecast period. Germany’s huge FMCG firms would positively affect national growth in the near future. France held over 12% shares (regarding volumes) in 2014. 

Demand for paints across multiple applications, specifically construction, could propel the France market. Key companies operating in the Europe aerosol container market encompass Ball Corporation, Plastipak Holdings, Arnest Group, and TUBEX Holding GmbH. 

Browse Related Category Market Reports @  https://www.hexaresearch.com/research-category/advanced-interior-materials

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Allergy Diagnostics and Therapeutics Market To Grow at a CAGR Exceeding 12% Till 2022

The global Allergy Diagnostics and Therapeutics Market is anticipated to grow at a CAGR exceeding 12% during the forecast period (2016 to 2022). This attributes to the problem of environmental pollution and high incidence of allergic diseases. The probability of children below 14 years of age being afflicted with chronic allergies is a prominent factor that fuels industry demand. Frequent need for in-vitro blood tests may drive this market over the forecast period. Widespread adoption of diagnostics for treating inhaled allergies caused by air pollution could significantly contribute to demand. Nowadays, people are highly susceptible to allergies because of changing lifestyles, unhealthy dietary patterns, and urbanization. 

The worldwide allergy diagnostics and therapeutics market is categorized on the basis of products, type of allergens, end uses, tests, drug classes, and geographies. On the basis of products, the segments are services, consumables, and instruments. Immunoassay analyzers, luminometers, and other diagnostic devices are few of the commonly used equipment. Popularity of immunoassay analyzers is by far the highest in most developing economies of the world. Various types of allergens are drug allergens, inhaled allergens, food allergens, and others. Inhaled allergens held the highest industry share over the past couple of years because of numerous cases of air pollution based allergies. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/allergy-diagnostic-market

Based on end uses, the industry is trifurcated into diagnostics laboratories, and academic research institutes. Types of tests mainly include the following: in-vitro, patch, intradermal, skin prick, and in vivo. As per drug classes, the divisions are immunotherapy, autoinjectable epinephrine, immunomodulators, decongestants, nasal anticholinergics, leukotriene inhibitors, mast cell stabilizers, corticosteroids, and antihistamines. 

Geographically, the worldwide allergy diagnostics and therapeutics market is divided into Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa. Over the past couple of years, North America has been dominating the global market in terms of revenue earnings. The region may continue leading the industry over the forecast period. Growing acceptance of in vitro blood tests, awareness about allergy diagnostics, and rising cases of allergic respiratory anomalies are drivers of this region. 

Europe is expected to register a high rate of growth because the region boasts of a mature pharmaceuticals industry. Surging demand for therapeutics is also a prominent regional driver. Other factors are rising cases allergic conditions and a rapidly expanding geriatric population. Asia Pacific may expand rapidly till 2022 owing to a rapidly developing medical infrastructure and surging demand for minimally invasive diagnostics solutions. 

The global allergy diagnostics and therapeutics market is a highly fragmented one with a host of companies continuously striving towards larger market shares. Lincoln Diagnostics, Siemens Healthcare, Hitachi Chemical Diagnostics, Alcon Laboratories, and Hycor Biomedical are some of the prominent competitors operating in the global market. 

In May 2016, Thermo Fisher Scientific licensed ProBioGen AG’s GlymaxX® technology for the development of allergy diagnostics. ProBioGen AG is a Germany based CDMO (contract development and manufacturing organization) & technology provider. Its key areas of focus are GMP production of biopharmaceuticals, process development, and cell lining engineering. The GlymaxX® technology yields antibodies with lower fucose content, is applicable to different types of species, needs no culture additives, and can even lead to enhanced productivity. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Molecular Diagnostics Market To Grow at a CAGR of Around 9% Till 2024

The Molecular Diagnostics Market was valued at over USD 6.40 billion in 2015. It is likely to grow at a CAGR of around 9% during the forecast period (2016-2024). 

Increasing prevalence of infectious diseases, cancer, genetic disorders, and other contagious disease are likely to drive the molecular diagnostics industry. Hospital acquired infections and other communicable infections are expected to boost market growth in the coming eight years. Moreover prenatal genetic testing is also expected to increase the adoption of this diagnostics. 

Unhealthy lifestyle can further contribute to large number of people getting afflicted with chronic ailments like cardiovascular disorders and diabetes. This with further propel market growth in the coming years. Molecular diagnostics market is divided into products, technologies, applications, test location, and regions. 

On the basis of products, the market is split into instruments, reagents, and others. Reagents segment held the largest share in 2015 with revenues exceeding USD 3.5 billion. It is expected to grow at a CAGR surpasing 12%. Instruments segment is expected to show a significant growth in the coming years. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/molecular-diagnostics-industry 

Technologies consist of polymerase chain reaction (PCR), in-situ hybridization, chips and microarrays, mass spectrometery, DNA sequencing, transportation mediated amplification, and others. PCR held the largest market share of over USD 2.5 billion in 2015. Growth of this segment can be attributed to its high incorporation among the researchers and healthcare professionals. DNA sequencing is likely to show a growth of about 16% CAGR in the coming years. 

Applications encompass oncology, pharmacogenomics, infectious diseases, genetic testing, neurological diseases, cardiovascular diseases, and others. Infectious diseases segment was the largest application holding market share exceeding 45% in 2015. 

Oncology segment is anticipated to show a CAGR of about 13% till 2024. Rising awareness among people regarding early cancer diagnosis is the key aspect propelling market growth of the segment. 

Test location comprises of point of care (PoC), self test or over the counter (OTC), and central laboratories. Central laboratories dominated the market with over 60% shares in 2015. The growth of the central laboratories can be attributed to their large prominence in underdeveloped countries, rising awareness about early detection of diseases, and high procedure volumes. 

The PoC is expected to project a lucrative growth with a CAGR of more than 14%. The growth of this segment can be attributed to the increasing demand of bedside patient monitoring and innovative technological devices. 

Regions are fragmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA). America dominated the market with over 40% revenue share. Asia Pacific is likely to exhibit a growth of around 12%CAGR in the coming years. 

The key global players of the molecular diagnostics market include Siemens Healthcare GmbH, Novartis AG (Grifols), F. Hoffmann-La Roche Limited, and Johnson & Johnson. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Home Infusion Therapy Market is Projected at USD 28.5 Billion by 2024

The worldwide Home Infusion Therapy Market is projected at USD 28.5 billion by 2024. It stood nearly USD 13.5 billion in 2015. This growth can be attributed to emphasis on ‘home infusion cost-containment’ as compared to ‘in-patient settings.’ Additionally, long-term savings for chronic ailments linked to the therapy should propel market sales in the forecast period (2016 to 2024). 

The elderly, in general, are more prone to chronic illnesses and often need infusion. So, rise in geriatric base also drives market growth. Demand for ‘home healthcare’ facilities from patients suffering chronic conditions & disabilities fuels market incomes. Surging demand for lowering readmissions & in-patient stays has led market participants to adopt competitive strategies. This has prompted home infusion devices to garner added sales. 

Alternate site & home services have increased due to the advantages of home infusion. The same, coupled with familiarity with such treatments, is also anticipated to drive the market till 2024. Moreover, availability of infusible drugs owing to heavy research & developments by market players provides lucrative prospects. Product initiatives & advancements also contribute market revenues. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/home-infusion-therapy-market 

Furthermore, home infusion helps patients avoid hospital acquired infections, thereby propelling the market. The market is split by applications, products, and geographies. Applications comprise parenteral nutrition and anti-infective. The latter occupied shares exceeding 27 percent in 2015. Its ‘IV push’ procedure has gained recognition and may grow further. 

Needleless connectors and infusion pumps constitute market products. Infusion pumps captured significant shares in 2015. They are widely adopted for nutrient & medicine delivery and preferred over manual drug delivery. The former would display over 9 percent CAGR during 2016 to 2024. Work safety at hospitals & other medical institutions due to HIV & Hepatitis transmission (from blood transfusions & needle stick injuries) drive the demand for this product. 

Geographies consist of Europe, Asia Pacific, North America, Middle East & Africa, and Latin America. North America led the market in 2015. It had over 45 percent shares that year. Asia Pacific should grow at the fastest CAGR in the near future. Key participants in the worldwide home infusion therapy market are Baxter, Inc.; CareFusion Corporation; ICU Medical, Inc.; and Terumo Corporation. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Tissue Engineering Market to Exceed USD 94.7 Billion Till 2024

The global Tissue Engineering Market was valued to be around USD 23.2 billion in 2015 and further expected to exceed USD 94.7 billion at a growing of CAGR 23% over the foreseeable period. Growing needs to bridge the gap between organ demand & supply are expected to drive the industry demand in the near future. Growing popularity in a variety of sectors including urological products, neurology, burn treatment etc. is also anticipated to boost the market growth. Organs developed using this method have high efficiency and durability. Rising applications of this method from surgical treatment of tissues and prosthetics to liver, corneal, cardiac tissue engineering is said to propel the growth from 2016 to 2024. The global market is categorized as applications and regions. 

The applications include GI & gynecology, cancer, cord blood & cell banking, skin or integumentary, urology, dental, musculoskeletal, spine, orthopedics, neurology, and cardiology & vascular. The orthopedic application sector occupied more than half of the total market share in 2015. The sector is further expected to continue leading the market on account of the increased number of bone implants due to accidents as well as a geriatric population base. The neurology sector is one of the fastest-growing application sectors since it has the wider scope for development. In addition to this, a significant amount of research in the neurology sector is also anticipated to drive the sector growth. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/tissue-engineering-market Regionally, North America dominated the global tissue engineering market in 2015 accounting for the largest share. It is further projected to continue its dominance even during the forecast period. This can be attributed to the presence of leading players in the region and high financial support for R&D from the government as well as some private organizations. The Asia-Pacific region is expected to be the most lucrative region in the near future. This is mainly because of the existence of immense manpower and highly developed procedures coupled with government funding. The European market is said to register reasonable growth prospects due to the presence of stringent regulatory rules. 

Major players in the tissue engineering market are acquiring and working in partnerships with small-scale companies so as to influence technology & research advancements and to expand the product portfolio. Some of the key players include Sanofi S. A.; CryoLife Inc.; StemCells Inc.; and BioMimetic Therapeutics Inc. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Guidewires Market To Grow At A Lucrative Rate By 2024 | Hexa Research

Guidewires are flexible tubes used to guide a catheter to a diseased artery in the heart. They are used for the diagnosis of cardiovascular diseases. It will face huge demand due to the recent trend of minimally invasive procedures. Benefits of these procedures such as fast recovery, reduced hospital stay, and a painless surgical experience will favor the Guidewires Market. 

The growing geriatric population and presence of prevalent coronary diseases are factors that can result in increased demand. The guidewires market is projected to grow at a rapid rate from 2016 to 2024 (forecast phase). Reservations by reimbursement companies will hamper the market growth. 

Coronary, peripheral, neurovascular, and urology guidewires are the 4 products currently offered in the market. All these products will be of prominent use in the medical sector in the years ahead. In 2013, Terumo Corporation dominated the peripheral guidewires market on account of its expansive product portfolio. Additionally, prominent players of neurovascular guidewires include ASAHI INTECC and Codman Neurovascular. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/guidewires-industry 

Regions include North America, Latin America, Asia Pacific, Europe, and Middle East & Africa (MEA). North America will lead the guidewires market over the next eight years. This can be attributed to the advanced health infrastructure and cardiovascular and neurovascular diseases in the region. Presence of large manufacturers and their respective specialty products will also favor the regional market growth. Asia Pacific will be the fastest growing market, owing its growth to the economies of China and India. 

Research and development play a key role pertaining to the growth of the global market. The companies involved have tried to create cost-effective products to prevent any product recalls. Tip shape retention and flexibility are the prime requirements of health practitioners while handling guidewires. Well-known players in the market are ASAHI INTECC, Terumo Corporation, Boston Scientific Corporation, and Abbott Laboratories. 

New product launches and collaborations with healthcare practitioners are a common strategy followed by these players. For instance, Boston Scientific has launched Safari preshaped TAVI guidewires, Fathom Steerable Guidewires, choice Floppy guidewires, Journey Guidewire, and Kinetix Guidewires. The Fathom series has advanced micro fabrication technology which can be used to treat tortuous vasculature. Safari series can retain its shape and comes in three sizes. 

Browse Related Category Market Reports @

https://www.hexaresearch.com/research-category/medical-devices-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/

[healthcarereports-blog]

Craniomaxillofacial Devices Market Growing At  A CAGR of over 6.7% Till 2024

The global Craniomaxillofacial Devices Market value is expected to exceed USD 1.71 billion by 2024 growing at an estimated CAGR of over 6.7% from 2016 to 2024. Demand for minimal invasive procedures which can heal rapidly is the primary driving factor of the market. Awareness of these surgeries by ASCFS and ISCFS will facilitate in market growth. Bigger healthcare budget, use of 3D implants in reconstructive surgery, and growing geriatric populace are other aspects favoring the market.

The global market is segmented according to products, materials, applications, and regions. Products include cranial flap fixation, MF (maxillofacial) plate and screw fixation, bone graft substitutes, and CMF distraction. Plate and screw fixation earned over 70% market revenue shares in 2014 due to their varied use in surgeries. 

Materials used are metal, bioabsorable, and alloys. Titanium alloys are used to produce cranial plates due to their low weight & non-corrosive property. Polymers such as PMMA (poly methyl methacrylate) and Medpor are used due to their biocompatible nature. Biomaterials such as PDLLA and PPEK are used in bioabsorbable devices. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/craniomaxillofacial-market

Neurosurgery & ENT, orthognathic & dental, plastic surgery, and others constitute as market applications. Increasing cases of spinal disorders will bring in revenues from the neurosurgery & ENT segment. Plastic surgery will see growth in the years ahead from developed countries of Canada and U.S. 

Regions covered under the market are Latin America, North America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for over 58% market revenue in 2014. Other factors supporting market growth in the region are technological developments, healthcare infrastructure, and high patient awareness. 

Europe is in need of technology which can cater to plate and screw fixation, thoracic fixation, CMF bone graft substitutes, and temperomandibular joint (TMJ) replacement. This is expected to net revenues over USD 227 million in 2013. Asia Pacific will exhibit growth due to economic development and improving healthcare infrastructure. 

Well-known players of the craniomaxillofacial devices market are Aesculap; Johnson & Johnson (DePuy Synthes); Boston Medical Products Inc.; and Medartis AG. Research and development of products are one of the strategies followed by players. For instance, Aesculap introduced Pro space, a osteoconductive interbody fusion method in 2015. 

Browse Related Category Market Reports @  https://www.hexaresearch.com/research-category/medical-devices-industry

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. 

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/